Imutran Limited – Trademark Portfolio

Entity Type: 03

Imutran Limited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. The owner is based in London EC1N 2DY.

21 Holborn Viaduct

London EC1N 2DY , GB

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IMUTRAN
IMUTRAN
Abandoned 1996

Trademark Classifications

Imutran Limited's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does Imutran Limited have?

Imutran Limited has 1 U.S. trademark filed with the USPTO.

What trademark classes does Imutran Limited file in?

Imutran Limited files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Imutran Limited's trademark registration success rate?

Imutran Limited has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.